28th Annual Mount Sinai Winter Symposium ADVANCES in MEDICAL, SURGICAL and COSMETIC DERMATOLOGY

Friday, December 5, 2025, 7:00 AM - Sunday, December 7, 2025, 7:00 PM, New York Academy of Medicine, New York, NY


This activity will provide comprehensive education pertaining to the medical, surgical and cosmetic Dermatology. The audience will be introduced to the latest naval techniques for hard-to-treat dermatological diseases and for achieving best therapeutical outcomes.

1. Identify and analyze new and important studies in medical, surgical/cosmetic dermatology, and dermatopathology.
2. Apply the most current research on the diagnosis and treatment of medical dermatological conditions, such as alopecia areata, psoriasis, eczema, actinic keratosis, rosacea, and skin cancer
3. Compare and contrast new surgical techniques including surgical closures and cosmetic procedures and apply them to their practice.
4. Identify new cosmetic agents, including fillers and neurotoxins, and learn injection techniques that can improve patient safety and outcomes.
5. Improve skills by observing live patient demonstrations using approved devices for the treatment of photodamage and age-related skin changes
6. Recognize, manage and appropriately treat unusual skin conditions, including the use of new relevant injectable and IV infusion treatment
7. Assess the various new modalities for evaluating and treating melanoma.
8. Demonstrate noninvasive options for fat augmentation via proper dispensing/injecting of the deoxycholic acid.

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (19.50 hours), Non-Physician Attendance (19.50 hours)

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Mitigation of Relevant Financial Relationships

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all accredited CE educational activities. All individuals in control of content of an activity accredited by ISMMS are expected to disclose all their financial relationships with ineligible companies existing within the prior 24 months. All relevant financial relationships have been mitigated and disclosed to learners before the activity takes place.